Cargando…
Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10‐Year Follow‐Up Study
BACKGROUND: As an initial treatment strategy, percutaneous coronary intervention (PCI) for coronary chronic total occlusion (CTO) did not show midterm survival benefits compared with optimal medical therapy (OMT). We sought to evaluate the benefit of PCI compared with OMT in patients with CTO over e...
Autores principales: | Park, Taek Kyu, Lee, Seung Hun, Choi, Ki Hong, Lee, Joo Myung, Yang, Jeong Hoon, Song, Young Bin, Hahn, Joo‐Yong, Choi, Jin‐Ho, Gwon, Hyeon‐Cheol, Lee, Sang Hoon, Choi, Seung‐Hyuk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174228/ https://www.ncbi.nlm.nih.gov/pubmed/33660515 http://dx.doi.org/10.1161/JAHA.120.019022 |
Ejemplares similares
-
Duration of dual antiplatelet therapy in patients treated with percutaneous coronary intervention for coronary chronic total occlusion
por: Lee, Seung Hwa, et al.
Publicado: (2017) -
Prognosis and Medical Cost of Measuring Fractional Flow Reserve in Percutaneous Coronary Intervention
por: Hong, David, et al.
Publicado: (2022) -
Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention with or without Preprocedural Exercise Stress Test
por: Kim, Jihoon, et al.
Publicado: (2019) -
Clinical Implications of Early Exercise Treadmill Testing after Percutaneous Coronary Intervention in the Drug-eluting Stent Era
por: Cho, Sung Woo, et al.
Publicado: (2020) -
Long-term Survival Benefit of Statin in Patients with Coronary Chronic Total Occlusion without Revascularization
por: Kim, Bum Sung, et al.
Publicado: (2018)